Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Center for Outcomes Research in Liver Diseases is a specialized liver-disease outcomes research and consulting organization focused on patient-reported outcomes, health economics, real-world data analysis, systematic reviews, meta-analyses, and disease registries. The group appears to operate as an active LLC and uses the COR-LD/CORLD brand, with CLDQ LLC also referenced on its website and in business listings. Its work centers on chronic liver diseases including MASLD/MASH, viral hepatitis, alcohol-related liver disease, cholestatic liver disease, cirrhosis, and liver transplantation. The organization is known for developing and validating liver-specific quality-of-life instruments such as the Chronic Liver Disease Questionnaire family and for coordinating global collaborations and registries in liver disease. Rather than a drug developer, it functions more like a healthcare research, evidence-generation, and advisory organization serving academic, clinical, and industry stakeholders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Outcomes Research in Liver Diseases.